Steris | STE - Current Liabilities



Steris reported $926.6M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
3M USD 7.81B 1.64B Jun/2025
Avanos Medical USD 134.6M 2.6M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Boston Scientific USD 5.06B 1.34B Mar/2025
CONMED USD 294.84M 11.69M Jun/2025
Cooper Companies USD 1.01B 2.4M Jul/2025
Dexcom USD 3.31B 271.6M Jun/2025
Ecolab USD 4.91B 299.3M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Fortive USD 3.75B 1.02B Jun/2025
Getinge SEK 15.05B 169M Dec/2024
Globus Medical USD 424.66M 39.96M Jun/2025
Haemonetics USD 531.41M 46.71M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Idexx Laboratories USD 1.22B 87.67M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Masimo USD 592.1M 45.6M Jun/2025
Olympus JPY 351.93B 73.43B Jun/2025
Owens Minor USD 1.96B 86.48M Mar/2025
ResMed USD 1.02B 78.6M Jun/2025
Steris USD 926.6M 95.57M Jun/2025
Stryker USD 7.29B 641M Jun/2025
Tandem Diabetes Care USD 251.69M 36.48M Jun/2025
Teleflex USD 716.15M 40.24M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Zimmer Biomet Holdings USD 2.7B 404.6M Jun/2025